4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001209191-23-046691
Chief Financial Officer sold 4,718 shares at $2.80 ($13,210)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dulac Edward J III Chief Financial Officer | 2023-08-18 | Sale | −4,718 | $2.80 | $13,210 | 119,570 | D |
| Open-market sales · 4,718 sh · avg $2.80 · $13,210 | |||||||
Loading xslF345X05/doc4.xml…